Latest filing published 03 Mar 2021 for Glycorex Transplantation, €2,853.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pontus Nobréus: trading record in brief
All filings by Pontus Nobréus on record concern Glycorex Transplantation. Between 27 November 2020 and 3 March 2021, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 3 purchases worth €14k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2021, the count stands at 2 purchases and no sales.
Half of the purchases are above €4,917 and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 3 March 2021: an open-market purchase of €2,853, in Glycorex Transplantation. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Pontus Nobréus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ SEK 9.64100.0% of flowAktieISIN SE0000524530FI:A001Q883-1Canonical exit: 1 Jun 2021 (T+90)
- 5,000 shares@ SEK 9.9035.3% of flowAktieISIN SE0000524530FI:csv-79bda911edccfd0d517cCanonical exit: 22 Apr 2021 (T+90)
- 5,000 shares@ SEK 12.5068.3% of flowAktieISIN SE0000524530FI:csv-c6396546b7b442d5e81dCanonical exit: 25 Feb 2021 (T+90)
3 of 3 declarations